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OBJECTIVE: To compare a family informant’s report of memory loss in
an older family member to standardized clinical diagnoses of cognitive
impairment.
SETTING: Duke Established Populations for Epidemiologic Studies of
the Elderly (EPESE), a 10-year longitudinal study of community dwell-
ers aged 65 and greater in five counties of North Carolina.
PARTICIPANTS: A stratified random sample of potentially demented
participants was selected from the second wave of the Duke EPESE
using responses to a brief cognitive screen. A neuropsychological
battery was administered to these participants, and their family in-
formants were asked whether they recognized memory loss in the
participant. One hundred fifty-seven participants completed the full
evaluation and also had an available family informant.
MAIN OUTCOME MEASURES: Family informant’s report of memory
loss (yes, no, sometimes) compared to expert consensus diagnosis of
cognitive impairment or dementia.
RESULTS: There was poor concordance between the clinical diagnoses
of cognitive impairment or dementia and the family informant’s recog-
nition of memory loss (k=0.05; P=.74). When informants reported
memory loss, 30% of participants were found not to have a cognitive
loss. Among participants in whom family informants reported no
memory loss, 75% were diagnosed with dementia or cognitive impair-
ment (sensitivity, 0.70, 95% confidence interval [CI], 0.61 to 0.78;
specificity, 0.24, 95% CI, 0.13 to 0.40; positive predictive value, 70%;
negative predictive value, 25%).
CONCLUSIONS: Asking family members about memory loss in a pa-
tient may be an unreliable strategy to detect dementia.
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D ementia and clinically significant memory impairmentare common, and are associated with substantial mor-
bidity.1–4 However, detection of dementia in primary care is
poor.5,6 Among community residents with dementia, dementia
is not recognized in 2 out of 3 people who see their physi-
cian.7,8 If clinicians recognize cognitive impairment, they can
address safety issues before urgent needs arise, and can in
some instances prolong quality of life by prescribing medica-
tions directed at slowing disease progression.1,3,9 They can
also prepare patients and family for the realities of a difficult
illness.
Recognizing memory loss is central to diagnosing demen-
tia and to defining mild cognitive impairment.10 Ten percent to
12% of patients diagnosed with mild cognitive impairment go
on to develop dementia within 1 year.11–13 However, people
with dementia frequently do not complain of memory loss, nor
do they endorse it when questioned.5,6 Therefore, clinicians
may rely on informants, usually family members, to report
signs of dementia in older patients. This is understandable
given the time limitations in the primary care setting, particu-
larly when the possibility of dementia is not the occasion for
the visit.
The accuracy of informant reporting on persons with
dementia has been addressed primarily in the context of
performing research. Investigators have raised concerns about
the reliability of informant reporting in research studies in-
volving demented participants.14,15 In a systematic review that
evaluated the validity of informant responses in studies of
older adults, results showed that informants performed well
on most factual and objective measures, but tended to
describe more impairment in functioning and emotional
well-being than was seen in the subject, a finding that was
particularly marked in subjects with cognitive impairment.16
Fewer studies specifically address informant recognition
of cognitive impairment, and the results are mixed. In out-
patient clinic populations, where patients or families have
recognized symptoms and initiated dementia-related care,
informant reporting of impairment generally agrees with clini-
cal findings.14 The only study we identified from a primary care
population, however, showed that when informants were
asked about specific aspects of the patient’s cognitive func-
tioning, the corresponding psychometric tests in the patient
were concordant only 60% of the time.17 On the other hand, in
several studies of community dwellers, informant’s responses
to structured questionnaires were concordant with results of
participant’s cognitive testing,18,19 and in a study including
hospitalized patients, combining cognitive testing of the parti-
cipant with results from a structured informant report in-
creased the accuracy of detecting dementia.20
The constraints of primary care often prevent the routine
use of structured questionnaires for family members of pa-
tients. While clinicians are more likely to ask family members
informal questions about memory impairment in their older
patients, the accuracy of these responses is unknown. The
purpose of this study is to compare a family informant’s report
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about memory loss with a standardized clinical diagnosis of
cognitive impairment or dementia.
METHODS
This work is a cross-sectional analysis of a subsample from
the Duke Established Populations for Epidemiologic Studies of
the Elderly (EPESE), one of four national sites funded by the
National Institute on Aging to investigate prospectively the
health and functional status of persons aged 65 years and
older in the United States.21 To improve statistical precision
in racial comparisons, the Duke site oversampled African
Americans. Data were collected from the index community-
dwelling older adult (hereafter referred to as the ‘‘participant’’)
and from a family member (hereafter referred to as the ‘‘infor-
mant’’) identified as the closest contact. The Institutional Review
Board of Duke University Medical Center approved the study.
Our study sample (Fig. 1) was drawn from the Duke
EPESE second in-person wave (1989 to 1990; N=3,337). Each
participant had completed the Short Portable Mental Status
Questionnaire (SPMSQ),22 a 10-item screen of cognitive func-
tion that when adjusted shows little race or education bias. To
select a subsample of participants with a spectrum of cognitive
functioning, but enriched with those likely to have dementia,
SPMSQ scores were classified as unimpaired, marginally
impaired, or cognitively impaired based on race- and educa-
tion-adjusted cut points. Randomized sampling from each
category23 yielded 343 participants who consented to partici-
pate in this study. Because this substudy oversampled for
cognitive impairment, participants are not representative of
the Duke EPESE population.
All interviews were conducted in participants’ homes.
Information was collected from participants (with assistance
from informants), about the participants’ demographic char-
acteristics, functional status, and health status. Ability to
perform activities of daily living (ADL) was determined by
responses based on the Katz ADL scale24 and the Older
Americans Resources and Services instrumental ADL scale.25
Participants then completed the Consortium to Establish a
Registry for Alzheimer’s Disease (CERAD) Neuropsychological
Battery.26 This battery included 5 measures, tapping areas of
cognitive function implicated in Alzheimer’s disease: verbal
fluency; confrontational naming; the Mini Mental State Exam-
ination (MMSE)27; word list learning, recall, and recognition;
and constructional praxis. The clock-drawing test from the
CERAD Clinical Battery was added.
Simultaneously at the same interview, structured ques-
tionnaires were administered to informants regarding the
participants’ behavior, personality, and ability to care for
themselves. Additionally, the informant was specifically asked,
‘‘Does he/she (participant) have a memory loss?’’ Possible
responses were ‘‘yes,’’ ‘‘no,’’ and ‘‘sometimes.’’
Participants were selected for a full clinical evaluation if
they complained of poor memory or their informant mentioned
this, scored less than 24 (if white) or 18 (if African American) on
the MMSE,28 had an inadequate drawing of a clock, recalled
fewer than 3 items from a 10-item word list recall task, or
appeared significantly memory impaired to the interviewer.
One hundred eighty-three participants met these criteria and
received a clinical evaluation. This included an in-home evalua-
tion by a project-trained clinical research nurse, a review of all
available medical records within the last 5 years, and the
administration of the CERAD Clinical Battery expanded to
include dementias other than Alzheimer’s disease. The CERAD
Clinical Battery focuses on health history relevant to dementia,
depression, medications, ability to perform instrumental and
basic ADLs, and language ability. It includes measures of cog-
nitive function and brief physical and neurological assessments.
Two experienced clinicians (a geriatrician and a neurolo-
gist) independently reviewed clinical evaluation data and a
consensus diagnosis was reached. These diagnoses were re-
lated to a specific etiology when possible, based on criteria
defined by the Diagnostic and Statistical Manual of Mental
Disorders-IV and the criteria for Alzheimer’s disease from the
National Institute of Neurological and Communicative Disor-
ders and Stroke-Alzheimer’s Disease and Related Disorders
Association.29 Cognitive impairment was defined as clinically
significant memory loss which nevertheless did not affect
ability to perform activities of daily living. We used descriptive
statistics to characterize the sample of participants and family
informants. k was used to test for agreement beyond chance
between family informant responses about participant mem-
ory loss and clinical diagnosis of dementia or cognitive impair-
ment.30 Sensitivity, specificity, and likelihood ratios were
calculated to determine the accuracy with which the question
about memory loss identified dementia.
RESULTS
Of the 343 participants who agreed to the study, 183 com-
pleted a full clinical evaluation for dementia. We included only
those participants who received this evaluation and also had a
family informant, resulting in a final sample of 157. The
absence of an available informant accounted for all ineligible
participants.
Participants had an average age of 75 years, and half had
no education beyond grade school (Table 1). Sixty-five percent
of the participants were African-American, and the median
FIGURE 1. Study sample. Based on DSM-IV, National Institute of
Neurological Diseases and Stroke-Alzheimer’s Disease and Related
Disorders Association criteria. EPESE, Established Populations for
Epidemiologic Studies of the Elderly; SPMSQ, Short Portable Mental
Status Questionnaire, a brief 10-item cognitive screen; CERAD,
Consortium to Establish a Registry for Alzheimer’s Disease neurop-
sychological battery, a comprehensive cognitive evaluation by
trained interviewers.
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MMSE score was 18/30. The majority of participants had
multiple medical conditions, and also commonly required
assistance with basic and instrumental ADLs.
Family informants had an average age of 60 (range, 26–
93); 77% were female, and they had known the participant an
average of 43 years. Most were daughters (29%), followed by
extended family (22%), spouses (16%), sons (13%), formal
caregivers (10%), and friends (10%).
Of the 157 participants undergoing full clinical evaluation
for dementia, 112 (71%) had clinically significant memory
impairment as determined by clinical consensus diagnosis.
Among those with significant impairment, 19 (17%) were
cognitively impaired and 93 (83%) met criteria for dementia.
Of those classified as demented, 54 (58%) had Alzheimer’s
disease, 17 (18%) vascular dementia, 8 (9%) a combination of
Alzheimer’s disease and vascular dementia, 13 (14%) dementia
of unknown etiology, and 1 (1%), alcohol dementia.
The agreement between family informant report of mem-
ory loss and a clinical diagnosis of cognitive impairment or
dementia resulted in a k of 0.05, indicating no agreement
beyond chance. These findings persisted when we excluded
participants with mild cognitive impairment (n=19) and when
we stratified by participant race.
Among participants whose informants reported memory
loss (answering ‘‘yes’’ or ‘‘sometimes’’ when asked whether the
participant had memory loss; n=113), clinical evaluation
revealed significant cognitive impairment or dementia in 79
participants (70%); however, in 34 participants (30%), clinical
evaluation did not identify any cognitive loss. Among the 44
participants for whom informants reported no memory loss,
clinical evaluation revealed significant cognitive impairment or
dementia in 33 participants (75%) (Table 2).
Using the question about memory loss as a diagnostic test
for detecting cognitive impairment or dementia, the sensitivity
was 0.70 (95% confidence interval [CI], 0.62 to 0.78) and the
specificity was 0.24 (95% CI, 0.13 to 0.40). This corresponded
to a positive predictive value (PPV) of 70% and a negative
predictive value (NPV) of 25%.
DISCUSSION
In a community sample of older adults selected for possible
cognitive impairment, we found poor concordance between
informant’s report about memory loss and the presence or
absence of clinically diagnosed dementia or cognitive impair-
ment in the participant. Well-acquainted family informants
frequently did not report memory loss in the participant de-
spite a clinical diagnosis of dementia. They also commonly
perceived a memory loss when thorough clinical evaluation
revealed no cognitive loss. These results suggest that clini-
cians should not depend on a family member to detect demen-
tia. However, family members who initiate a visit or
spontaneously report memory problems in the patient should
undoubtedly be taken seriously.
Families may not report memory loss in older adults for
several reasons. They may view it as a normal part of aging, or
not recognize slow progressive change.2,31 Families may also
be unwilling to accept that someone on whom they depend is
decompensating. Stigma about dementia, often perceived as
‘‘losing your mind,’’ is also a challenge in older adults and their
spouses fearful about loss of independence.32,33 Consistent
with the reviews on proxy reporting,16,34 informants may be
able to report accurately on observable signs, but be less
accurate when reporting on subjective signs such as memory
loss. Finally, some informants may be impaired themselves,
and thus unable to recognize memory loss in others.
In contrast, informants in our study who reported mem-
ory loss in the absence of a clinical diagnosis of impairment
may have been recognizing benign forgetfulness. Because
informants were free to interpret the meaning of ‘‘memory
loss,’’ we cannot draw conclusions about what threshold of
severity they deemed important. These results suggest that
there likely is variation in the definition and interpretation of
memory loss.
We acknowledge several limitations. Our study selected
for cognitively impaired individuals and, therefore, does not
reflect the community at large. We also examined only one
Table 1. Patient Characteristics (N=157)
Mean age, y (range) 75 (65 to 92)
Median years education 7.5
African American 102 (65)







Heart disease 47 (30)
Stroke 31 (20)
Diabetes 30 (19)







Handling money 94 (60)










Values expressed as number (percentage) unless otherwise noted.
wHealth conditions in the patient were defined by report of the patient/
family informant when asked what diagnoses had been given by a
physician.
MMSE, Mini Mental State Exam.
Table 2. Family Informant’s Report of Memory Loss Versus Clinical
Diagnosis of Dementia or Cognitive Impairment
Informant Reports Memory Loss Clinical Diagnosis Total
Yes No
Yes/sometimes 79 34 113
No 33 11 44
Total 112 45 157
k=0.05; P= .74; sensitivity, 70%; specificity, 24%; positive predictive
value, 70%; negative predictive value, 25%.
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target question in reference to memory impairment. There is
no specific evidence to support that this question mimics
clinical practice, but our collective experiences in primary care
and with our colleagues suggest that clinicians commonly ask
older patients and their family about memory loss (likely
because it is the key feature of dementia) without any further
inquiry. Finally, small cell sizes limited our ability to perform
subgroup analyses among those categorized as demented,
which may have revealed improved concordance with increas-
ing severity. It should be noted, however, that this sample was
enriched for impairment (median MMSE, 18).
Participants included both African Americans (65% of our
sample) and whites; cultural differences in accepting, recog-
nizing, and reportingmemory impairmentmay be present.35,36
It has been shown that African-American caregivers may
choose not to seek care for dementia outside of the family
system, and that they often ‘‘normalize’’ demented behaviors to
fit their cultural values.36 Similarly, in one study of Yoruba
Nigerian and African-American elderly, caregivers recognized
personality change, not memory loss, as the initial sign of
dementia.35 These and other potential cultural perspectives
may have influenced the responses to our study questions.
These findings support the use of valid and reliable
measures to screen for dementia in vulnerable older adults.
Fortunately, several brief cognitive screens have been shown
to be accurate and easily administered. For instance, Borson
et al. have developed the ‘‘mini-cog,’’ which includes 3 recall
questions and a clock-drawing test.37 Callahan et al. have
developed a 6-item screen, which evaluates recall and orienta-
tion, and shows good discriminate ability for varying levels of
cognitive impairment; the absence of clock drawing in this
instrument allows for an even briefer administration time.38
These and similar measures can also be administered in the
waiting room by trained personnel, allowing the physician to
focus on patients with positive screens.
Our results show poor concordance between family re-
cognition of memory loss and clinical diagnoses of cognitive
impairment or dementia. As clinicians, we must not rely on
family members to detect dementia in our patients. Although
informant input is crucial to the definitive diagnosis and
management of dementia, families may not be consistent in
recognizing the onset of memory loss and initiating treatment.
Routine, structured screening, reinforced with family educa-
tion about normal versus abnormal aging, may help overcome
the complex barriers to identifying dementia.
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